Search Within

Hematology-Oncology Fellows

  1. "2024"
Formats
  1. Meeting Abstract (128)
  2. Journal Article (119)
  3. Review (28)
  4. Editorial (11)
  5. Research Letter (8)
  6. Correspondence (4)
  7. Book Section (2)
  8. Guidelines (1)
Groups
  1. Graduate Medical Education (262)
  2. GME, Medicine (259)
  3. Department of Medicine (232)
  4. Weinberg Fellows (162)
  5. Hematologic Malignancies, Division of (139)
  6. Solid Tumor Oncology Division (139)

More Groups

People
  1. Michael Scordo (29)
  2. Gunjan Shah (27)
  3. Saad Usmani (24)
  4. Sergio Giralt (24)
  5. Jan Bewersdorf (22)
  6. Kylee Maclachlan (22)

More People

Years
  1. 2024 (301)
Publications
  1. Journal of Clinical Oncology (67)
  2. Blood (32)
  3. Clinical Lymphoma, Myeloma and Leukemia (11)
  4. Annals of Oncology (10)
  5. Blood Advances (9)
  6. Clinical Cancer Research (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (74)
  2. American Society of Hematology (44)
  3. Elsevier Inc. (36)
  4. Nature Publishing Group (28)
  5. American Association for Cancer Research (17)
  6. Oxford University Press (16)

More Publishers

Results (301)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multidimensional analysis of B7 homolog 3 (B7-H3) RNA expression in small-cell lung cancer (SCLC) molecular subtypes
    Meeting Abstract

    Gay, C. M.; Owonikoko, T. K.; Byers, L. A.; Choudhury, N. J.; Ahmed, S.; Cain, Z.; Qian, X. Z.; Brentnall, M.; Heeke, S.; Poi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • PD-L1 immunohistochemistry in gastric cancer: Comparison of combined positive score and tumor area positivity across 28-8, 22C3, and SP263 assays
    Meeting Abstract

    Klempner, S. J.; Cowden, E. S.; Cytryn, S. L.; Fassan, M.; Kawakami, H.; Shimada, H.; Tang, L. H.; Wagner, D. C.; Yatabe, Y.; Savchenko, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • CCNE1 amplification as marker of poor prognosis and novel therapeutic target in advanced breast cancer
    Meeting Abstract

    Marra, A.; Selenica, P.; Zhu, Y.; Safonov, A.; Razavi, P.; Roulston, A.; Koehler, M.; Curigliano, G.; Ross, D. S.; Weigelt, B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • TTF-1 negativity as a biomarker of outcomes to immunotherapy, chemoimmunotherapy, and KRAS G12C inhibitors in lung adenocarcinoma
    Meeting Abstract

    Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Shaverdian, N.; Ricciuti, B.; Alessi, J. V. M.; De Giglio, A.; Pecci, F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Shareable artificial intelligence to extract cancer outcomes from electronic health records
    Meeting Abstract

    Kehl, K. L.; Jee, J.; Pichotta, K.; Trukhanov, P.; Fong, C.; Waters, M.; Nichols, C.; Cerami, E.; Schrag, D.; Schultz, N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2-early breast cancer (EBC) treated with endocrine therapy (ET) in the US
    Meeting Abstract

    Razavi, P.; Ahmed, M.; Roush, A.; Parikh, R.; Hitchens, A.; Shen, S.; Safonov, A.; Jhaveri, K. L.; Robson, M. E.; Peacock, N. W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1 results of the WEE1 inhibitor, azenosertib, in combination with gemcitabine (gem) in adult and pediatric patients (pts) with relapsed or refractory (R/R) osteosarcoma
    Meeting Abstract

    Avutu, V.; Livingston, J. A.; Federman, N.; Cranmer, L. D.; Gaspar, N.; Toulmonde, M.; Pressey, J. G.; Brahmi, M.; Poklepovic, A. S.; Shi, Q.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Glucagon-like peptide-1 (GLP-1) agonist use and weight change among patients with breast cancer
    Meeting Abstract

    Shen, S.; Liu, B.; Fanti, C.; Bromberg, M.; Chen, Y.; Chang, C.; Iyengar, N. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A multi-institution analysis of outcomes with first-line systemic therapy for 99 patients with metastatic chromophobe renal cell carcinoma
    Meeting Abstract

    Doshi, S. D.; Dizman, N.; Knezevic, A.; Touma, A.; Alaghehbandan, R.; Ged, Y.; Ornstein, M. C.; Hahn, A. W.; Msaouel, P.; Voss, M. H.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Endometrial carcinoma in Black vs Asian women: Racial disparities and opportunities to improve survival in 219,301 patients in the USA
    Meeting Abstract

    Becerra, H. A.; Ilerhunmwuwa, N. P.; Wasifuddin, M.; Uche, I.; Osorio, J. C.; Wang, J. C. C.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save